Corticosteroid therapy of eye disease. Fifty years later.
Raizman
M
M
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D005128:Eye Diseases / Q000188:drug therapy*; D005469:Fluorometholone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000139:chemically induced; D009883:Ophthalmic Solutions; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D011245:Pregnadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D009883:Ophthalmic Solutions; D011245:Pregnadienes; D003907:Dexamethasone; C009935:prednisolone acetate; D011239:Prednisolone; C013769:rimexolone; D005469:Fluorometholone